This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Korwek, E.L. 1981. OSHA Regulation of Industrial Applications of Recombinant DNA Technology. U. Cinn. L. Rev. 50: 284.
Nutrilab, Inc. v. Schweiker. 1982. Food Drug Cosm. L. Rep. (CCH) ¶ 38,188 (N.D. Ill. 1982).
FD&C Act, 1976. § 201(g)(1)(C), 21 U.S.C. § 321(g)(1)(C).
Biotics Research Corp. v. Schweiker. 1982. Food Drug Cosm. L. Rep. (CCH) ¶ 38,160 (D. Nev. 1982).
Korwek, E.L. 1982. FDA Regulation of Biotechnology as a New Method of Manufacture. Food Drug Cosm. L. J. 37: 289.
Korwek, E.L. and Trinker, D. 1981. Perspectives on the FDA Status of Drug Products Manufactured by the Recombinant DNA Technique. Food Drug Cosm. L. J. 36: 517.
Fed. Reg. 47: 26,458 (June 18, 1982).
Korwek, E.L. 1983. USDA's Role in Regulating Biotechnology: Growing Daily. Biotechnology and the Law Conference, Keller and Heckman, Washington, D.C.
United States v. Generix Drug Corp., slip op. at 8 (Mar. 22, 1983).
5 Recombinant DNA Technical Bulletin 177 (1982).
Korwek, E.L. 1982. FDA, OSHA and EPA Regulation of the Recombinant DNA Technology. J. Parenteral Sci. and Tech. 26: 251, 253–55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Korwek, E. Regulatory Trends for Biotechnology Products. Nat Biotechnol 1, 240–246 (1983). https://doi.org/10.1038/nbt0583-240
Issue date:
DOI: https://doi.org/10.1038/nbt0583-240